Ушбу иш иқтибос қилган ишлар

87 та иш

Иш: Naringenin as a potent anti-amyloidogenic polyphenol against a-synuclein aggregation: a computational approach

1. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

   Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry +9

   Шарҳ мақола20152 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.591762

2. 7,8‐dihydroxyflavone Ameliorates Motor Deficits Via Suppressing <i>α</i> ‐synuclein Expression and Oxidative Stress in the <scp>MPTP</scp> ‐induced Mouse Model of Parkinson's Disease

   Xiaohuan Li, Chunfang Dai, Long Chen +3

   Мақола20162 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.591764

3. Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice

   Darrell Sawmiller, Ahsan Habib, Song Li +8

   Мақола20162 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.591765

4. Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models

   Hayate Javed, Mohamed Fizur Nagoor Meeran, Sheikh Azimullah +3

   Шарҳ мақола20192 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.591775

5. Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship

   Jiao Li, Min Sun, Xiaodong Cui +1

   Шарҳ мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.591788

6. Evaluation of Expression of Cytochrome P450 Aromatase and Inflammatory, Oxidative, and Apoptotic Markers in Testicular Tissue of Obese Rats (Pre)Treated with Garlic Powder

   Li Baicheng, Jia Li, Abolfazl Akbari +2

   Мақола20232 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.591789

7. Computational insight into in silico analysis and molecular dynamics simulation of the dimer interface residues of ALS-linked hSOD1 forms in apo/holo states: a combined experimental and bioinformatic perspective

   Hamza Dakhil Zaji, Bagher Seyedalipour, Haider Munzer Hanun +3

   Мақола20232 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.591790

8. The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma

   Nasim Ebrahimi, Nazanin Pazhouhesh Far, Siavash Seifollahy Fakhr +11

   Шарҳ мақола20232 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.591793

9. Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami

   Yasamin Sharbatdar, Ronak Mousavian, Seyed Mostafa Noorbakhsh Varnosfaderani +9

   Шарҳ мақола20232 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.591794

10. Polyphenolic flavonoid compounds act as the inhibitory potential of aggregation process: Implications for the prevention and therapeutics against FALS-associated D101G SOD1 mutant

    Hussein maitham Qassim, Bagher Seyedalipour, Payam Baziyar +1

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591797

11. Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation

    Seyed Mostafa Noorbakhsh Varnosfaderani, Melika Sadat Haeri, Ali Sam Arian +7

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591799

12. Mutation/metal deficiency in the "electrostatic loop" enhanced aggregation process in apo/holo SOD1 variants: implications for ALS diseases

    Faezeh Ashkaran, Bagher Seyedalipour, Payam Baziyar +1

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591802

13. Discovering the therapeutic potential of Naringenin in diabetes related to GLUT-4 and its regulatory factors: A computational approach

    Ali Khakpour, Shamim Ghiabi, Ali Kazemi Babaheydari +4

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591803

14. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591731

15. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591733

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591735

17. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591736

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591738

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591739

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591740

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591741

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591743

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591744

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591745

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.591746